Evoke Pharma, Inc.
EVOK
$5.49
$0.0761.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.06M | 12.62M | 13.60M | 11.34M | 9.18M |
| Total Receivables | 2.91M | 2.51M | 2.42M | 2.02M | 2.00M |
| Inventory | 641.90K | 532.10K | 445.10K | 493.40K | 544.80K |
| Prepaid Expenses | 288.60K | 523.90K | 731.90K | 146.70K | 382.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 36.10K | 39.20K | 43.90K | 36.40K | 27.70K |
| Total Current Assets | 15.93M | 16.23M | 17.24M | 14.04M | 12.14M |
|
|
|||||
| Total Current Assets | 15.93M | 16.23M | 17.24M | 14.04M | 12.14M |
| Net Property, Plant & Equipment | 122.90K | 138.80K | 154.20K | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 6.30K | 6.30K | 126.90K | 115.50K | -- |
| Total Assets | 16.06M | 16.38M | 17.52M | 14.15M | 12.14M |
|
|
|||||
| Total Accounts Payable | 3.19M | 2.28M | 2.04M | 1.90M | 1.90M |
| Total Accrued Expenses | 3.17M | 2.81M | 3.18M | 2.71M | 2.42M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.06M | 5.06M | 5.06M | 5.00M | 5.00M |
| Total Finance Division Other Current Liabilities | 200.00K | 300.00K | 100.00K | 160.00K | 152.00K |
| Total Other Current Liabilities | 200.00K | 300.00K | 100.00K | 160.00K | 152.00K |
| Total Current Liabilities | 11.62M | 10.45M | 10.38M | 9.77M | 9.47M |
|
|
|||||
| Total Current Liabilities | 11.62M | 10.45M | 10.38M | 9.77M | 9.47M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 65.00K | 83.20K | 101.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 11.69M | 10.53M | 10.48M | 9.77M | 9.47M |
|
|
|||||
| Common Stock & APIC | 136.04M | 135.94M | 135.83M | 131.99M | 128.95M |
| Retained Earnings | -131.67M | -130.10M | -128.79M | -127.60M | -126.29M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 4.37M | 5.84M | 7.04M | 4.39M | 2.67M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.37M | 5.84M | 7.04M | 4.39M | 2.67M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.37M | 5.84M | 7.04M | 4.39M | 2.67M |
|
|
|||||